Published in Lab Law Weekly, August 25th, 2006
The U.S. Food and Drug Administration (FDA) recently released MedImmune's first lots of FluMist, allowing distribution to begin. MedImmune expects to have all lots of FluMist approved and released for commercial sale by late fall.
The CDC's ACIP recently expanded its original routine influenza vaccination guidelines to include household contacts of high-risk...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.